Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cibus, Inc.

Cibus, Inc. (CBUS) Stock Overview

Explore Cibus, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CBUS●NASDAQ
HealthcareBiotechnology
$1.70
$0.00(0.00%)
U.S. Market opens in 6h 25m

Cibus, Inc. (CBUS)

Meyka AI Score

Z

Key Financials

Market Cap129.8M
P/E Ratio-1.18
EPS (TTM)$-1.80
ROE-3.21%
Fundamental Analysis

AI Price Forecasts

1 Month$1.76
3 Months$1.71
1 Year Target$0.00

CBUS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cibus, Inc. (NASDAQ: CBUS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Cibus, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CBUS on the NASDAQ shows an RSI of 45.34, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Cibus, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.18 and a market capitalization of 129.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CBUS on the NASDAQ.

Price Performance (NASDAQ: CBUS)

1-Day Change
N/A
5-Day Change
-1.73%
1-Month Change
-8.60%
3-Month Change
23.19%
6-Month Change
-43.14%
Year-to-Date (YTD) Change
-2.30%
1-Year Change
36.00%
3-Year Change
-89.93%
5-Year Change
-99.00%
All-Time (Max) Change
-99.70%

Contact Information

https://www.cibus.com
858 450 0008
6455 Nancy Ridge Drive, San Diego, CA, 92121

Company Facts

1,180 Employees
IPO DateJul 20, 2017
CountryUS
Actively Trading

Frequently Asked Questions